Clinical Trial Update: Study in Mild Asthmatic Patients [Phase 2]

View source ↗

Summary

GlaxoSmithKline's Phase 2 trial in mild asthma patients has completed; the snippet does not report the study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED